Hepatitis C virus and hepatocarcinogenesis
- PMID: 23323249
- PMCID: PMC3540370
- DOI: 10.3350/cmh.2012.18.4.347
Hepatitis C virus and hepatocarcinogenesis
Abstract
Hepatitis C virus (HCV) is an RNA virus that is unable to integrate into the host genome. However, its proteins interact with various host proteins and induce host responses. The oncogenic process of HCV infection is slow and insidious and probably requires multiple steps of genetic and epigenetic alterations, the activation of cellular oncogenes, the inactivation of tumor suppressor genes, and dysregulation of multiple signal transduction pathways. Stellate cells may transdifferentiate into progenitor cells and possibly be linked to the development of hepatocellular carcinoma (HCC). Viral proteins also have been implicated in several cellular signal transduction pathways that affect cell survival, proliferation, migration and transformation. Current advances in gene expression profile and selective messenger RNA analysis have improved approach to the pathogenesis of HCC. The heterogeneity of genetic events observed in HCV-related HCCs has suggested that complex mechanisms underlie malignant transformation induced by HCV infection. Considering the complexity and heterogeneity of HCCs of both etiological and genetic aspects, further molecular classification is required and an understanding of these molecular complexities may provide the opportunity for effective chemoprevention and personalized therapy for HCV-related HCC patients in the future. In this review, we summarize the current knowledge of the mechanisms of hepatocarcinogenesis induced by HCV infection.
Keywords: Hepatitis C virus; Hepatocellular carcinoma; Molecular.
Conflict of interest statement
The authors have no conflicts to disclose.
Figures
Similar articles
-
Hepatitis C virus-associated cancer.Annu Rev Pathol. 2015;10:345-70. doi: 10.1146/annurev-pathol-012414-040323. Epub 2014 Nov 5. Annu Rev Pathol. 2015. PMID: 25387053 Review.
-
Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA.Mol Med Rep. 2015 Oct;12(4):5109-15. doi: 10.3892/mmr.2015.4041. Epub 2015 Jul 3. Mol Med Rep. 2015. PMID: 26151503
-
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.World J Gastroenterol. 2016 Jan 28;22(4):1497-512. doi: 10.3748/wjg.v22.i4.1497. World J Gastroenterol. 2016. PMID: 26819517 Free PMC article. Review.
-
Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.J Biol Chem. 2017 Dec 29;292(52):21676-21689. doi: 10.1074/jbc.M117.792721. Epub 2017 Oct 27. J Biol Chem. 2017. PMID: 29079574 Free PMC article.
-
Pathways and gene expression profiles in hepatocellular carcinoma.Minerva Gastroenterol Dietol. 2012 Mar;58(1):35-48. Minerva Gastroenterol Dietol. 2012. PMID: 22419003 Review.
Cited by
-
Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.PLoS One. 2018 Sep 27;13(9):e0204412. doi: 10.1371/journal.pone.0204412. eCollection 2018. PLoS One. 2018. PMID: 30260995 Free PMC article.
-
Microbiome in human cancers.Access Microbiol. 2021 Aug 11;3(8):000247. doi: 10.1099/acmi.0.000247. eCollection 2021. Access Microbiol. 2021. PMID: 34888478 Free PMC article. Review.
-
Viruses and the nucleolus: the fatal attraction.Biochim Biophys Acta. 2014 Jun;1842(6):840-7. doi: 10.1016/j.bbadis.2013.12.010. Epub 2013 Dec 27. Biochim Biophys Acta. 2014. PMID: 24378568 Free PMC article.
-
Comparison of gene expression in liver regeneration and hepatocellular carcinoma formation.Cancer Manag Res. 2018 Nov 15;10:5691-5708. doi: 10.2147/CMAR.S172945. eCollection 2018. Cancer Manag Res. 2018. PMID: 30532592 Free PMC article.
-
Human viral oncogenesis: a cancer hallmarks analysis.Cell Host Microbe. 2014 Mar 12;15(3):266-82. doi: 10.1016/j.chom.2014.02.011. Cell Host Microbe. 2014. PMID: 24629334 Free PMC article. Review.
References
-
- El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. - PubMed
-
- Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol. 2009;50:453–460. - PubMed
-
- Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2:1004–1006. - PubMed
-
- Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989;2:1006–1008. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical